Madou Marc, Zoval Jim, Jia Guangyao, Kido Horacio, Kim Jitae, Kim Nahui
Department of Mechanical and Aerospace Engineering, University of California, Irvine, California 92697, USA.
Annu Rev Biomed Eng. 2006;8:601-28. doi: 10.1146/annurev.bioeng.8.061505.095758.
In this paper, centrifuge-based microfluidic platforms are reviewed and compared with other popular microfluidic propulsion methods. The underlying physical principles of centrifugal pumping in microfluidic systems are presented and the various centrifuge fluidic functions, such as valving, decanting, calibration, mixing, metering, heating, sample splitting, and separation, are introduced. Those fluidic functions have been combined with analytical measurement techniques, such as optical imaging, absorbance, and fluorescence spectroscopy and mass spectrometry, to make the centrifugal platform a powerful solution for medical and clinical diagnostics and high throughput screening (HTS) in drug discovery. Applications of a compact disc (CD)-based centrifuge platform analyzed in this review include two-point calibration of an optode-based ion sensor, an automated immunoassay platform, multiple parallel screening assays, and cellular-based assays. The use of modified commercial CD drives for high-resolution optical imaging is discussed as well. From a broader perspective, we compare technical barriers involved in applying microfluidics for sensing and diagnostic use and applying such techniques to HTS. The latter poses less challenges and explains why HTS products based on a CD fluidic platform are already commercially available, whereas we might have to wait longer to see commercial CD-based diagnostics.
本文对基于离心机的微流控平台进行了综述,并与其他常用的微流控推进方法进行了比较。介绍了微流控系统中离心泵送的基本物理原理,并介绍了各种离心流体功能,如阀门控制、倾析、校准、混合、计量、加热、样品分流和分离。这些流体功能已与光学成像、吸光度、荧光光谱和质谱等分析测量技术相结合,使离心平台成为医学和临床诊断以及药物发现中的高通量筛选(HTS)的强大解决方案。本综述分析的基于光盘(CD)的离心机平台的应用包括基于光极的离子传感器的两点校准、自动化免疫分析平台、多个平行筛选分析和基于细胞的分析。还讨论了使用改进的商用CD驱动器进行高分辨率光学成像。从更广泛的角度来看,我们比较了将微流控技术应用于传感和诊断用途以及将此类技术应用于高通量筛选所涉及的技术障碍。后者面临的挑战较小,这也解释了为什么基于CD流体平台的高通量筛选产品已经商业化,而基于CD的诊断产品可能还需要更长时间才能上市。